Drug Safety Alerts

DSA01: Tablet CALAMOX 375mg has been declared SUB-STANDARD by Drugs Testing Laboratory Punjab! - 30th August, 2017.

DSA02: Capsules GEXIM 400mg has been declared SUB-STANDARD by Drugs Testing Laboratory Punjab! - 30th August, 2017.

DSA03: Veterinary Medicine Solution DELTABACK has been declared SUB-STANDARD by Drugs Testing Laboratory Punjab! - 30th August, 2017.

DSA04: Veterinary Injection Pred CPM 50ml has been declared SUB-STANDARD and MISBRANDED by Drugs Testing Laboratory Punjab! - 5th September, 2017. 

DSA05: Capsule OMICIN 500mg has been declared ADULTERATED by Drugs Testing Laboratory Punjab! - 5th September, 2017.

DSA06: Aqua-P Water for Injection 5ml has been declared SUB-STANDARD by Drugs Testing Laboratory Punjab! - 5th September, 2017

DSA07: Eye Drops EYEBRADEX 5ml has been declared SUB-STANDARD by Drugs Testing Laboratory Punjab! - 5th September, 2017

DSA08: Suspension METZIL 60ml has been declared SUB-STANDARD by Drugs Testing Laboratory Punjab! - 5th September, 2017

DSA09: Suspension NOCER 10mg/5ml has been declared SUB-STANDARD by Drugs Testing Laboratory Punjab! - 5th September, 2017

DSA010: Veterinary Injection PREDNOBAK 50ml has been declared SUB-STANDARD and MISBRANDED by Drugs Testing Laboratory Punjab! - 5th September, 2017

DSA011: Several Batches of Medicines have been declared SUBSTANDARD by the Drugs Testing Laboratory Punjab subsequently prosecuted by the Provincial Quality Control Board Punjab! - 8th September, 2017.

DSA012 Several Batches of Medicines have been declared SUBSTANDARD by the Drugs Testing Laboratory Punjab subsequently prosecuted by the Provincial Quality Control Board Punjab! 8th September, 2017.

DSA013: Gadolinium-based Contrast Agents for Magnetic Resonance Imaging - No Harmful Effects Identified with Brain Retention! - 13th September, 2017.

DSA014 Suspension Tempol 6+ 60ML (Approx.) has been declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 20th September, 2017.

DSA015 Stop Using Homeopathic Teething Products Marketed by “Hyland’s! - 27th September, 2017.

DSA016 Chlorhexidine Gluconate - Rare But Serious Allergic Reactions! - 27th September, 2017.

DSA017 Intraocular Vancomycin May Cause HORV leading to blindness! - 7th October, 2017.

DSA018 Risk of QT-Interval with Hydroxyzine! - 9th October, 2017.

DSA019 Federal DRAP Fluoroquinolones include Levofloxacin, Ciprofloxacin should be reserved....! - 9th October, 2017.

DSA020 Infusion Ciprofloxacin (Quilox-Bosch), Adverse Drug Event Reported from DHQ Layyah! - 16th October, 2017.

DSA021 Reduce the Use of Antibiotics in Food-Producing Animals to Prevent the Spread of Antibiotic Resistance! - 11th November, 2017.

DSA022 Steven Johnson Syndrome (SJS)! - 11th November, 2017.

DSA023: Capsule SONA PLUS AMSAKI AMBER WALA Suspected by Allopathic Ingredient “Sildenafil Citrate” by Drug Testing Laboratory (DTL) Punjab! - 17th November, 2017.

DSA024: Capsule MILLAN Suspected by Allopathic Ingredient “Sildenafil Citrate” by Drug Testing Laboratory (DTL) Punjab! - 17th November, 2017.

DSA025: Suspension NOCER has been declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 17th November, 2017.

DSA026: Patients with Cow’s Milk Allergy Should Not Use Methylprednisolone Injectable Medicine that Contain Lactose (Solu-Medrol 40mg)! - 20th November, 2017.

DSA027: Suspension H2-foz has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 27th November, 2017.

DSA028: Syrup Bronchilate has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 27th November, 2017.

DSA029: Lotion BENZO has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 30th November, 2017.

DSA030: Biotin (Vitamin B7) Supplements Can Cause Incorrect Lab Test Results! - 30th November, 2017.

DSA031: Tablet VASCAM has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 8th December, 2017.

DSA032: Capsule MOGALIS Suspected by Allopathic Ingredient “Sildenafil Citrate” by Drug Testing Laboratory (DTL) Punjab! - 8th December, 2017.

DSA033: Suspension AMBPOFEN has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 8th December, 2017.

DSA034: Syrup DENOL-DM has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 14th December, 2017.

DSA035: Avoid concomitant use of Omeprazole and Clopidogrel! - 14th December, 2017.

DSA036 France Orders International Recall of Celia Lactalis over Salmonella Fears! - 15th December, 2017.

DSA037: France Orders Recall of Celia Lactalis over Salmonella Fears of following contaminated Batches! - 15th December, 2017.

DSA038: INFOSAN Orders International Recall of Gromore (Milk) over Salmonella Agona Contamination! - 21st December, 2017.

DSA039: Drug interaction IV Ceftriaxone-Calcium Gluconate! - 1st January, 2018.

DSA040: An awareness into the H1N1 Influenza (Swine Flu) Virus Infection! - 1st January, 2018.

DSA041: Provincial Drug Control Unit (PDCU) has issued a guideline for prevention and early detection of Steven Johnsons Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)! - 9th January, 2018.

DSA042: Consider following points for prevention of Adverse Drug Reactions (ADRs)! - 9th January, 2018.

DSA043: Provincial Drug Control Unit (PDCU) has issued a guideline for prevention of Adverse Drug Reactions (ADRs)! - 9th January, 2018. 

DSA044: Tablet VEGA 100 Suspected to contain Allopathic Ingredient “Sildenafil Citrate” by Drug Testing Laboratory (DTL) Punjab! - 11th January, 2018.

DSA045: BLACK COBRA 125 Suspected to contain Allopathic Ingredient “Sildenafil Citrate” by Drug Testing Laboratory (DTL) Punjab! - 11th January, 2018.

DSA046: A Case Report of mouth sores related to Oral Azithromycin! - 11th January, 2018.

DSA047: Federal DRAP issued Withdrawal/Recall of the Synthetic Recombinant Bovine Somato-Tropin (RBST)! - 11th January, 2018.

DSA048: Tablet PENAGRA-100 Suspected to Contain Allopathic Ingredient “Sildenafil Citrate” by Drug Testing Laboratory (DTL) Punjab! - 18th January, 2018.

DSA049: Tablet SIZZLE has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 18th January, 2018.

DSA050: Relenza (Zanamivir) for inhalation is available in the market for treatment or prevention of influenza! - 19th January, 2018.

DSA051: FDA warns against use of Codeine and Hydrocodone in Paeds! - 22nd January, 2018. 

DSA052: Provincial Drug Control Unit received a case report of Anaphylaxis related to Injection Anti-Snake Venom (ASV)! - 25th January, 2018.

DSA053: Provincial Drug Control Unit received a case report of Omeprazole Allergy! - 25th January, 2018.

DSA054: Syrup MENSTROL Suspected to contain Ingredient “Ferrous Sulphate” by Drug Testing Laboratory (DTL) Punjab! - 25th January, 2018.

DSA055: Tablet LOPRID has been declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 25th January, 2018.

DSA056: Provincial Drug Control Unit received various reports of oral Moxifloxacin related hypotension in cardiac patients! - 26th January, 2018.

DSA057: Provincial Drug Control Unit received a report of Erythropoietin related hypertensive crisis in a patient with Chronic Kidney Disease! - 26th January, 2018. 

DSA058: Provincial Drug Control Unit received multiple reports of Infusion Ciprofloxacin related allergic symptoms from multiple health facilities in Punjab! - 26th January, 2018. 

DSA059: Tablet LETEC has been declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 30th January, 2018.

DSA060: Syrup AMVIT has been declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 30th January, 2018.

DSA061: Suspension VEFEC has been declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 2nd February, 2018.

DSA062: Anti-Diarrhea Medicine Loperamide (Imodium) may have Crisis! - 2nd February, 2018.

DSA063: Tablet PHRENNO Has Been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 28th February, 2018.

DSA064: Tablet H-Fan Has Been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 28th February, 2018.

DSA065: Suspension GRANID has been declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 28th February, 2018.

DSA066: “Cotton Wool” has been declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 28th February, 2018.

DSA067: Tablet DILZEM has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 9th March, 2018

DSA068: Suspension Parokal has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 9th March, 2018

DSA069: Recall of Sancos Syrup 120ml to ensure complete withdrawal! - 9th March, 2018

DSA070: PDCU received a case report of Gastrointestinal symptoms and Pancreatitis due to long term use of Piroxicam! - 9th March, 2018

DSA071: License of Everest Pharmaceuticals has been cancelled! - 12th March, 2018

DSA072: Eye Drops OPHTH-BIOVISC has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 14th March, 2018

DSA073: Tablet PHENOBAR has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 14th March, 2018

DSA074: Tablet CALAMOX has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 14th March, 2018

DSA075: Tablet CALAMOX (6 batches) has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 27th March, 2018 

DSA076: Tablet Cure-C 400mg has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 3rd April, 2018

DSA077: Tablet BLOMIC has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 3rd April, 2018

DSA078: Suspension ENCEPH 250mg/5ml has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 3rd April, 2018

DSA079: Injection Haemic has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 5th April, 2018 

DSA080: Capsule ESOFIN (Esomeprazole 20mg) has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 5th April, 2018 

DSA081: Tablet SIMVA has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 5th April, 2018 

DSA082: Tablet ANAC SR-100 has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 5th April, 2018 

DSA083: Capsule TRISAVE 500mg has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 10th April, 2018

DSA084: Tablet DIARTIN has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 10th April, 2018 

DSA085: Capsule EVASTIN has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 10th April, 2018 

DSA086: Injection Ivermex has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 10th April, 2018 

DSA087: Tablet Nimcid has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 14th April, 2018 

DSA088: Imperial Absorbent Cotton Wool has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 14th April, 2018  

DSA089: Syrup Zecit has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 14th April, 2018  

DSA090: Tablet Diclosave 50mg has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 14th April, 2018  

DSA091: Steriband [Gauze Swab: 10CM x 10CM (8 Ply)] has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 14th April, 2018  

DSA092: Tablet Axifen SR has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 19th April, 2018

DSA093: Sterile Water for Injection has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 19th April, 2018

DSA094: Tablet Volmax has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 19th April, 2018

DSA095: Suspension Climox has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 19th April, 2018 

DSA096: Tablet Rozen has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 19th April, 2018 

DSA097: Tablet Voveron SR has been Declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 19th April, 2018

Newsletter I- Drug Safety Punjab  - 01 June, 2018

DSA098: Risk of Severe Cutaneous Adverse Reactions (SCARs) by Epoetins! - 26th June, 2018

DSA099: Injection Ketor has been declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 26th June, 2018

DSA100: Injection Carasil 100ml has been declared SPURIOUS by Drug Testing Laboratory (DTL) Punjab! - 26th June, 2018

DSA101: Injection Penro (PO18012) has been declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 26th June, 2018

DSA102: Injection Penro (PO18019) has been declared SUB-STANDARD by Drug Testing Laboratory (DTL) Punjab! - 26th June, 2018

Newsletter II- Drug Safety Punjab - 01 July, 2018

DSA164: Provincial Drug Control Unit (PDCU) has received two reports of hypotension without allergic symptoms associated with use of Ceftriaxone sodium. - 09 July, 2018

DSA165: Provincial Drug Control Unit (PDCU) has received a report of seizures associated with use of Metronidazole. - 09 July, 2018

DSA166: Provincial Drug Control Unit (PDCU) has received multiple reports of muscular pains associated with use of Atorvastatin. - 09 July, 2018

DSA167: Recall of Valsartan Containing Medicines. - 12th July, 2018

DSA168: Recall of Valsartan Containing Medicines. - 16th July, 2018

1st Revision DSA168: Recall of Valsartan Containing Medicines. - 17th July, 2018

2nd Revision DSA168: Recall of Valsartan Containing Medicines. - 18th July, 2018

3rd Revision DSA168: Recall of Valsartan Containing Medicines. - 20th July, 2018

4th Revision DSA168: Recall of Valsartan Containing Medicines. - 24th July, 2018

Newsletter III- Drug Safety Punjab - 01 August, 2018

5th Revision DSA168: Recall of Valsartan Containing Medicines. - 08th August, 2018

Newsletter IV- Drug Safety Punjab - 01 September, 2018

DSA 318: Various issues reported regarding Tetanus Toxoid Vaccine. - 26th September, 2018

6th Revision DSA168: Recall of Valsartan Containing Medicines. - 27th September, 2018

Newsletter V- Drug Safety Punjab - 01 October, 2018

Newsletter VI- Drug Safety Punjab - 01 November, 2018

DSA 560: Voluntary Recall of Tablet JUMEX 5mg (Selegline HCL) Batch No. 7V001, Registration No. 0101215 by M/S Sanofi Aventis Pakistan Limited - 13th November, 2018

Newsletter VII- Drug Safety Punjab - 01 December, 2018

Newsletter VIII- Drug Safety Punjab - 01 January, 2019

Newsletter IX- Drug Safety Punjab - 01 February, 2019

Newsletter X- Drug Safety Punjab - 01 March, 2019

Newsletter XI- Drug Safety Punjab - 01 April, 2019

DSA 1053: Injection/Infusion Heparin Associated Hematuria Received Multiple Reports! - 17th April, 2019

DSA1054: Falsified Meglumine Antimoniate Ampoules in Pakistan! - 2nd May, 2019

DSA1162: Febuxostat: Increase Risk of Death! - 29th May, 2019

Newsletter XII- Drug Safety Punjab - 01 June, 2019

Newsletter XIII- Drug Safety Punjab - 01 July, 2019

DSA1242: Domperidon related Serious Cardiac Events in Children under 12 years of age! - 16th July, 2019

DSA1242 Revision 1.0: Domperidon related Serious Cardiac Events in Children under 12 years of age! - 22nd July, 2019

Newsletter XIV- Drug Safety Punjab - 01 August, 2019

Newsletter XV- Drug Safety Punjab - 01 September, 2019

DSA1504: Presence of Nitrosamine Impurity N-Nitrosodimethylamine (NDMA) in Ranitidine Medicine (Zantac) - 16 September, 2019

DSA1505: Injection CLOTIDE (Metoclopramide) 10mg/2ml, Batch No. CLI-060A, Manufactured by M/S Surge Laboratories Pvt. Ltd. District Sheikhupura has been declared SPURIOUS by Drug Testing Laboratory Punjab. 20th September, 2019

DSA1504 Revision 1.0: Medicine Recall - NDMA in Ranitidine Medicines - 24th September, 2019

Newsletter XVI- Drug Safety Punjab - 01 October, 2019

DSA1522: Tablet Rozen (Cetirizine Dihydrochloride) 10mg, Reg. No. 040161, Batch No. 8D534, Manufactured by M/S Rasco Pharma, Raiwind Road, Lahore has been declared Sub-Standard and Adulterated. 11th October, 2019

Newsletter XVII- Drug Safety Punjab - 01 November, 2019

Newsletter XVIII- Drug Safety Punjab - 04 December, 2019

DSA1553: Regulatory Recall of Medicines. 12th December, 2019

Newsletter XIX- Drug Safety Punjab - 06 January, 2020

Newsletter XX- Drug Safety Punjab - February, 2020

Newsletter XXI- Drug Safety Punjab - March, 2020

Newsletter XXII- Drug Safety Punjab - July, 2020

Newsletter XXIII- Drug Safety Punjab - September, 2020

Newsletter XXIV- Drug Safety Punjab - October, 2020

Newsletter XXV- Drug Safety Punjab - December, 2020

Newsletter XXVI- Drug Safety Punjab - January, 2021

Newsletter XXVII- Drug Safety Punjab - February, 2021

Newsletter XXVIII- Drug Safety Punjab - March, 2021

Newsletter XXIX- Drug Safety Punjab - April, 2021

Newsletter XXX- Drug Safety Punjab - May, 2021 

Newsletter XXXI- Drug Safety Punjab - June, 2021 

Newsletter XXXII- Drug Safety Punjab - July, 2021 

Newsletter XXXIII- Drug Safety Punjab - August, 2021 

Newsletter XXXIV- Drug Safety Punjab - September, 2021 

Newsletter XXXV- Drug Safety Punjab - November, 2021 

Newsletter XXXVI- Drug Safety Punjab - February, 2022 

Newsletter XXXVII- Drug Safety Punjab - May, 2022 

Newsletter XXXVIII- Drug Safety Punjab - September, 2022 

Newsletter XXXIX- Drug Safety Punjab - January, 2023